Clinical Trial Update: Phase 2a Pilot Study of NBMI Treatment in Patients With Beta Thalassemia Major, Requiring Iron Chelation [Phase 2]

View source ↗

Summary

Phase 2a pilot study update for NBMI treatment in beta-thalassemia major patients requiring iron chelation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta Thalassemia Major

Drugs mentioned

• NBMI

Snippet

Sponsor: EmeraMed | Conditions: Beta Thalassemia Major | Phase 2 | Status: COMPLETED